Compendia Bioscience is developing cutting edge cancer genomics products and services and we are looking for a Senior Scientist to join our team.
The individuals we are looking for:
Have a strong understanding of basic biology, cancer biology and genomics
Have a clear record of scientific success in industry or academia.
Are able to review and synthesize scientific data.
Are passionate about cancer genomics and cancer drug development.
Communicate well in person and in writing.
Enjoy working in the dynamic environment of a startup life sciences technology company.
PhD required; research experience with cancer pathways, cancer drug development and / or cancer genomics a plus; a strong publication record is highly valued and pharma experience is valued.
Compendia Bioscience collects, curates, analyzes, and visualizes the global collection of cancer genomic data, enabling us and our customers to understand connections between genes, diseases, and drug therapies. Started in 2006 and based on the Oncomine technology developed at the University of Michigan, Compendia Bioscience is a rapidly growing company providing products and services to the majority of major oncology pharma companies.
Individuals we hire will join our growing team of scientists and engineers, with significant interactions with R&D, Scientific Content, and Operations. This role will have direct responsibility for developing new strategies to leverage cancer genomics data for target discovery, biomarker discovery and personalized medicine.
Compendia's culture reflects the intellectual inquisitiveness and diverse abilities of our people. It is a place where advanced technology intersects with cutting edge scientific research: where an ad hoc meeting might be about a new next-generation sequencing technology, a new statistical analysis technique, a new dynamic visualization approach, a new application of ontology-based knowledge representation to search techniques, or an exciting new cancer research discovery. We are looking for people who are excited by such an environment, who like to learn, and who will contribute their own unique perspectives to our collective understanding of how we can harness the global collection of genomic data to help cure cancer.